A citation-based method for searching scientific literature

Megha A Parikh, Carrie P Aaron, Eric A Hoffman, Joseph E Schwartz, Jaime Madrigano, John H M Austin, Ravi Kalhan, Gina Lovasi, Karol Watson, Karen Hinckley Stukovsky, R Graham Barr. Ann Am Thorac Soc 2017
Times Cited: 32







List of co-cited articles
285 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
Gerard J Criner, John E Connett, Shawn D Aaron, Richard K Albert, William C Bailey, Richard Casaburi, J Allen D Cooper, Jeffrey L Curtis, Mark T Dransfield, MeiLan K Han,[...]. N Engl J Med 2014
210
28

Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use.
Hans Petersen, Akshay Sood, Paula M Meek, Xian Shen, Yan Cheng, Steven A Belinsky, Caroline A Owen, George Washko, Victor Pinto-Plata, Emer Kelly,[...]. Chest 2014
44
28

Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice.
Megan Podowski, Carla Calvi, Shana Metzger, Kaori Misono, Hataya Poonyagariyagorn, Armando Lopez-Mercado, Therese Ku, Thomas Lauer, Sharon McGrath-Morrow, Alan Berger,[...]. J Clin Invest 2012
88
28


A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.
Francesca Polverino, Maria E Laucho-Contreras, Hans Petersen, Vanesa Bijol, Lynette M Sholl, Mary E Choi, Miguel Divo, Victor Pinto-Plata, Alfredo Chetta, Yohannes Tesfaigzi,[...]. Am J Respir Crit Care Med 2017
49
21

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, Antonio Anzueto, Peter J Barnes, Jean Bourbeau, Bartolome R Celli, Rongchang Chen, Marc Decramer, Leonardo M Fabbri,[...]. Am J Respir Crit Care Med 2017
21

Impact of statins and ACE inhibitors on mortality after COPD exacerbations.
Eric M Mortensen, Laurel A Copeland, Mary Jo V Pugh, Marcos I Restrepo, Rosa Malo de Molina, Brandy Nakashima, Antonio Anzueto. Respir Res 2009
110
18

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
Jørgen Vestbo, Julie A Anderson, Robert D Brook, Peter M A Calverley, Bartolome R Celli, Courtney Crim, Fernando Martinez, Julie Yates, David E Newby. Lancet 2016
235
15

The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD.
Junghyun Kim, Jung-Kyu Lee, Eun Young Heo, Hee Soon Chung, Deog Kyeom Kim. Int J Chron Obstruct Pulmon Dis 2016
18
27

Percent emphysema, airflow obstruction, and impaired left ventricular filling.
R Graham Barr, David A Bluemke, Firas S Ahmed, J Jeffery Carr, Paul L Enright, Eric A Hoffman, Rui Jiang, Steven M Kawut, Richard A Kronmal, João A C Lima,[...]. N Engl J Med 2010
356
15

Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.
Sara Roversi, Leonardo M Fabbri, Don D Sin, Nathaniel M Hawkins, Alvar Agustí. Am J Respir Crit Care Med 2016
100
15

Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.
Magnus P Ekström, Anna Bornefalk Hermansson, Kerstin E Ström. Am J Respir Crit Care Med 2013
97
15

Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial.
S Andreas, C Herrmann-Lingen, T Raupach, L Lüthje, J A Fabricius, N Hruska, W Körber, B Büchner, C-P Criée, G Hasenfuss,[...]. Eur Respir J 2006
61
15

Cardioselective beta-blockers for chronic obstructive pulmonary disease.
S Salpeter, T Ormiston, E Salpeter. Cochrane Database Syst Rev 2005
198
15

Systemic manifestations and comorbidities of COPD.
P J Barnes, B R Celli. Eur Respir J 2009
922
15

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.
Y Kasahara, R M Tuder, L Taraseviciene-Stewart, T D Le Cras, S Abman, P K Hirth, J Waltenberger, N F Voelkel. J Clin Invest 2000
826
12

SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.
Jered P Sieren, John D Newell, R Graham Barr, Eugene R Bleecker, Nathan Burnette, Elizabeth E Carretta, David Couper, Jonathan Goldin, Junfeng Guo, MeiLan K Han,[...]. Am J Respir Crit Care Med 2016
114
12

Multi-Ethnic Study of Atherosclerosis: objectives and design.
Diane E Bild, David A Bluemke, Gregory L Burke, Robert Detrano, Ana V Diez Roux, Aaron R Folsom, Philip Greenland, David R Jacob, Richard Kronmal, Kiang Liu,[...]. Am J Epidemiol 2002
12

Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk.
N L Mills, J J Miller, A Anand, S D Robinson, G A Frazer, D Anderson, L Breen, I B Wilkinson, C M McEniery, K Donaldson,[...]. Thorax 2008
142
12

Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
Suellen M Curkendall, Cynthia DeLuise, Judith K Jones, Stephan Lanes, Mary Rose Stang, Earl Goehring, Dewei She. Ann Epidemiol 2006
416
12

Senescence in COPD and Its Comorbidities.
Peter J Barnes. Annu Rev Physiol 2017
92
12

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.
Miguel Divo, Claudia Cote, Juan P de Torres, Ciro Casanova, Jose M Marin, Victor Pinto-Plata, Javier Zulueta, Carlos Cabrera, Jorge Zagaceta, Gary Hunninghake,[...]. Am J Respir Crit Care Med 2012
655
12

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.
D M Mannino, D Thorn, A Swensen, F Holguin. Eur Respir J 2008
632
12

Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
Jens M Hohlfeld, Jens Vogel-Claussen, Heike Biller, Dominik Berliner, Korbinian Berschneider, Hanns-Christian Tillmann, Simone Hiltl, Johann Bauersachs, Tobias Welte. Lancet Respir Med 2018
75
12

Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study.
Carrie P Aaron, Eric A Hoffman, Joao A C Lima, Steven M Kawut, Alain G Bertoni, Jens Vogel-Claussen, Mohammadali Habibi, Katja Hueper, David R Jacobs, Ravi Kalhan,[...]. PLoS One 2017
25
16

Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
Ian S Stone, Neil C Barnes, Wai-Yee James, Dawn Midwinter, Redha Boubertakh, Richard Follows, Leonette John, Steffen E Petersen. Am J Respir Crit Care Med 2016
68
12

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
Peter M A Calverley, Julie A Anderson, Bartolome Celli, Gary T Ferguson, Christine Jenkins, Paul W Jones, Julie C Yates, Jørgen Vestbo. N Engl J Med 2007
9

Clinical and Radiologic Disease in Smokers With Normal Spirometry.
Elizabeth A Regan, David A Lynch, Douglas Curran-Everett, Jeffrey L Curtis, John H M Austin, Philippe A Grenier, Hans-Ulrich Kauczor, William C Bailey, Dawn L DeMeo, Richard H Casaburi,[...]. JAMA Intern Med 2015
225
9

Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study.
Elizabeth C Oelsner, Eric A Hoffman, Aaron R Folsom, J Jeffrey Carr, Paul L Enright, Steven M Kawut, Richard Kronmal, David Lederer, Joao A C Lima, Gina S Lovasi,[...]. Ann Intern Med 2014
58
9

CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society.
David A Lynch, John H M Austin, James C Hogg, Philippe A Grenier, Hans-Ulrich Kauczor, Alexander A Bankier, R Graham Barr, Thomas V Colby, Jeffrey R Galvin, Pierre Alain Gevenois,[...]. Radiology 2015
210
9


Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.
Katja Hueper, Jens Vogel-Claussen, Megha A Parikh, John H M Austin, David A Bluemke, James Carr, Jiwoong Choi, Thomas A Goldstein, Antoinette S Gomes, Eric A Hoffman,[...]. Am J Respir Crit Care Med 2015
90
9

Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
Michelle T Harrison, Philip Short, Peter A Williamson, Aran Singanayagam, James D Chalmers, Stuart Schembri. Thorax 2014
65
9

Increased platelet activation in patients with stable and acute exacerbation of COPD.
John D Maclay, David A McAllister, Shonna Johnston, Jennifer Raftis, Catherine McGuinnes, Andrew Deans, David E Newby, Nicholas L Mills, William MacNee. Thorax 2011
106
9

Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review.
Lies Lahousse, Henning Tiemeier, M Arfan Ikram, Guy G Brusselle. Respir Med 2015
57
9


Cardiovascular disease in COPD: mechanisms.
John D Maclay, William MacNee. Chest 2013
139
9

Cardiac effects of current treatments of chronic obstructive pulmonary disease.
Lies Lahousse, Katia M Verhamme, Bruno H Stricker, Guy G Brusselle. Lancet Respir Med 2016
59
9

Mortality in COPD: Role of comorbidities.
D D Sin, N R Anthonisen, J B Soriano, A G Agusti. Eur Respir J 2006
629
9

Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study.
R Graham Barr, Sonia Mesia-Vela, John H M Austin, Robert C Basner, Brad M Keller, Anthony P Reeves, Daichi Shimbo, Lori Stevenson. Am J Respir Crit Care Med 2007
171
9


Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.
Dinesh Shrikrishna, Ronan Astin, Paul R Kemp, Nicholas S Hopkinson. Clin Sci (Lond) 2012
53
9

Effect of angiotensin 2 receptor blockers on chronic obstructive lung disease mortality: A retrospective cohort study.
Pilar Paulin, Joaquin Maritano Furcada, Catalina M Ungaro, Gisela Bendelman, Gabriel D Waisman, Horacio M Castro, Diego H Giunta, Bruno L Ferreyro. Pulm Pharmacol Ther 2017
5
60

Efficacy and safety profile of xanthines in COPD: a network meta-analysis.
Mario Cazzola, Luigino Calzetta, Peter J Barnes, Gerard J Criner, Fernando J Martinez, Alberto Papi, Maria Gabriella Matera. Eur Respir Rev 2018
25
12

Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Sonal Singh, Yoon K Loke, Paul Enright, Curt D Furberg. Thorax 2013
69
9


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
9


The role of beta-blockers in the management of chronic obstructive pulmonary disease.
Fernando Sergio Leitao Filho, Nawaf M Alotaibi, Kei Yamasaki, David A Ngan, Don D Sin. Expert Rev Respir Med 2018
6
50

Lung function and exercise gas exchange in chronic heart failure.
K Wasserman, Y Y Zhang, A Gitt, R Belardinelli, A Koike, L Lubarsky, P G Agostoni. Circulation 1997
300
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.